
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 6 473-476, Copyright © 1998 by American Association for Cancer Research
ARTICLES |
A Yokoyama, T Ohmori, T Muramatsu, T Yokoyama, K Okuyama, H Makuuchi, H Takahashi, S Higuchi, M Hayashida, K Maruyama and H Ishii
National Institute on Alcoholism, Kurihama National Hospital, Kanagawa, Japan.
The risk of the future development of primary esophageal cancer after endoscopic esophageal mucosal resection of esophageal cancer is not known; hence, there are no established guidelines for follow-up surveillance programs. Simultaneous occurrence of multiple cancers associated with esophageal cancer is common among heavy drinkers who have the inactive form of aldehyde dehydrogenase-2 (ALDH2) as a risk factor. Thirty-four Japanese male alcoholics with intraepithelial or mucosal squamous cell carcinoma in the esophagus were treated by endoscopic esophageal mucosal resection, followed by endoscopy and esophageal iodine staining, to find the additional development of primary esophageal cancer. Primary esophageal squamous cell carcinoma was detected in nine patients (26.5%) at 3-21 months after the first cancer diagnosis. Cancer occurred more frequently in patients with inactive ALDH2 than it did in those with active ALDH2 [42.1% (8 of 19) versus 6.7% (1 of 15), P = 0.047], and it occurred more frequently in those with multiple esophageal cancers than it did in those without them [60.0% (6 of 10) versus 12.5% (3 of 24), P = 0.009]. Kaplan-Meier estimates of the proportions of patients with additional primary esophageal cancers showed that patients with inactive ALDH2 (P = 0.024) or multiple esophageal cancers (P = 0.007) had a significantly increased likelihood of the development of additional cancer. Close follow-up examinations using endoscopy and iodine staining are needed for such high-risk patients.
This article has been cited by other articles:
![]() |
T. Yokoyama, A. Yokoyama, Y. Kumagai, T. Omori, H. Kato, H. Igaki, T. Tsujinaka, M. Muto, M. Yokoyama, and H. Watanabe Health Risk Appraisal Models for Mass Screening of Esophageal Cancer in Japanese Men Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2846 - 2854. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yokoyama, T. Omori, T. Yokoyama, Y. Sato, T. Mizukami, S. Matsushita, S. Higuchi, K. Maruyama, H. Ishii, and T. Hibi Risk of Squamous Cell Carcinoma of the Upper Aerodigestive Tract in Cancer-Free Alcoholic Japanese Men: An Endoscopic Follow-up Study. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2209 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yokoyama and T. Omori Genetic Polymorphisms of Alcohol and Aldehyde Dehydrogenases and Risk for Esophageal and Head and Neck Cancers Jpn. J. Clin. Oncol., March 1, 2003; 33(3): 111 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yokoyama, H. Watanabe, H. Fukuda, T. Haneda, H. Kato, T. Yokoyama, T. Muramatsu, H. Igaki, and Y. Tachimori Multiple Cancers Associated with Esophageal and Oropharyngolaryngeal Squamous Cell Carcinoma and the Aldehyde Dehydrogenase-2 Genotype in Male Japanese Drinkers Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 895 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yokoyama, T. Muramatsu, T. Omori, T. Yokoyama, S. Matsushita, S. Higuchi, K. Maruyama, and H. Ishii Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics Carcinogenesis, March 1, 2001; 22(3): 433 - 439. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |